Aurinia Pharmaceuticals Inc

Halal Rating :
See Details
Last Price $5.05 Last updated:
Market Cap $752.01m
7D Change -1.27%
1 Year Change -53.11%

Company Overview

  • Health Technology
  • Biotechnology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing
Exchange NASDAQ
Next Earnings Date

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, develops and markets therapies to treat various diseases with unmet medical needs in Japan and China. The company is headquartered in Victoria, Canada.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Dec. 31, 2023 $45.09m $81.47m $4.57m $1.31m 10.13% 1.61%
Sept. 30, 2023 $53.12m $78.95m $4.51m $1.4m 8.50% 1.77%
June 30, 2023 $41.43m $59.29m $4.1m $65000.0 9.90% 0.11%

Company Impact

Help us evaluate Aurinia Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates